Alphatec Holdings (ATEC) | Stock Overview & Key Data
Alphatec Holdings Performance Comparison
Stock Range
Today's Range
Low: $13.54
High: $14.02
on October 6, 2025
52 Week Range
Low: $4.88
High: $16.70
on October 10, 2024
on September 4, 2025
All-Time High: $105.60 on June 12, 2006
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$2.2B
EPS
-1.13
P/E Ratio (TTM)
-12.35
Forward P/E
-21.48
P/B Ratio
86.17
PEG Ratio
1.79
Div. Yield
N/A
ROE
-376.89%
Beta
1.056
Debt to Equity
1,238.29
Financial Highlights
Profitability
Gross Margin
69.58%
Operating Margin
-6.19%
Profit Margin
-24.33%
Returns and Earnings
Return on Assets (TTM)
-7.61%
Return on Equity (TTM)
-376.89%
EBITDA
$-15.0M
Net Income (TTM)
$-166.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$4.73
Quarterly Revenue Growth (YoY)
27.50%
Quarterly Earnings Growth (YoY)
27.46%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Alphatec Holdings ATEC | 2.22B Mid-cap | -7.06% | -12.20% | 27.02% | 36.73% | 54.08% | 154.28% | 55.63% | 44.21% |
| Abbott Laboratories ABT | 234.39B Mega-cap | 0.78% | 1.82% | 0.11% | 2.25% | 18.64% | 19.49% | 32.22% | 22.75% |
| Boston Scientific BSX | 144.20B Large-cap | -0.88% | -9.50% | -6.71% | -1.20% | 8.88% | 15.12% | 144.77% | 136.56% |
| Bio-Rad BIO.B | 8.41B Mid-cap | 0.00% | 15.31% | 13.92% | 17.72% | -12.51% | -14.92% | -36.76% | -46.25% |
| Bio-Rad Laboratories BIO | 8.38B Mid-cap | 12.58% | 6.05% | 21.44% | 30.13% | -6.34% | -11.12% | -28.78% | -46.04% |
| Globus Medical GMED | 8.17B Mid-cap | 8.58% | 2.86% | 2.21% | -16.02% | -26.09% | -14.41% | 1.15% | 12.92% |
Ownership & Short Interest
Insider Ownership
20.69%
Institutional Ownership
69.09%
Shares Short
12M
Short Ratio
6.08
Short % of Shares Outstanding
10.10%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ATEC's 52-week high and low?
- In the last 52 weeks, Alphatec Holdings reached a high of $16.70 (on September 4, 2025) and a low of $4.88 (on October 10, 2024).
- What is the market cap and P/E ratio for ATEC?
- Curious about Alphatec Holdings's size and valuation? Its market capitalization stands at 2.22B. When it comes to valuation, the P/E ratio (trailing twelve months) is -12.35, and the forward P/E (looking ahead) is -21.48.
- Does ATEC pay dividends? If so, what's the yield?
- As for dividends, Alphatec Holdings isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Alphatec Holdings's main competitors or similar companies to consider before investing?
When looking at Alphatec Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT234.39B Healthcare Medical Devices 19.49% 32.22% Boston Scientific
BSX144.20B Healthcare Medical Devices 15.12% 144.77% Bio-Rad
BIO.B8.41B Healthcare Medical Devices -14.92% -36.76% Bio-Rad Laboratories
BIO8.38B Healthcare Medical Devices -11.12% -28.78% Globus Medical
GMED8.17B Healthcare Medical Devices -14.41% 1.15% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Alphatec Holdings Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Alphatec Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -376.89%, the Debt to Equity ratio from the most recent quarter is 1,238.29, and its Gross Profit Margin stands at 69.58%.
- What is the recent revenue and earnings growth for ATEC?
- Looking at Alphatec Holdings's growth, its revenue over the trailing twelve months (TTM) was $682M. Compared to the same quarter last year (YoY), quarterly revenue grew by 27.50%, and quarterly earnings saw a YoY growth of 27.46%.
- How much of ATEC stock is held by insiders and institutions?
- Wondering who owns Alphatec Holdings stock? Company insiders (like executives and directors) hold about 20.69% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 69.09%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.